Genedx Holdings Corp (WGS)

$128.87 +3.80 (3.04%)
Market Cap 3.59B
Revenue (ttm) 305.45M
Net Income (ttm) -52.29M
EPS (ttm) N/A
PE Ratio 79.61
Forward PE 103.43
Profit Margin -17.12%
Debt to Equity Ratio 0.19
Volume 482,800
Avg Vol 528,808
Day's Range N/A - N/A
Shares Out 28.73M
Stochastic %K 89%
Beta 1.98
Analysts Strong Sell
Price Target $127.41

Company Profile

GeneDx Holdings Corp., a genomics company, provides genetic testing services. It primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. The company also develops an AI-based platform for NGS analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. The company is headquartered in Stamford, Connecticut.

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 888 729 1206
Fax: 201 421 2010
Address:
North Tower, 6th Floor 333 Ludlow Street, Stamford, United States
Doozio
Doozio Oct. 24 at 11:31 PM
$WGS if $XBI is huckleberry riding then meet $DAVE all the way up da Roger. It’s 🐒🍌🧠⏰♾️
0 · Reply
StockbobSquaregainz
StockbobSquaregainz Oct. 24 at 11:09 PM
$WGS imagine if this ticker was trending one day…
0 · Reply
Doozio
Doozio Oct. 24 at 11:03 PM
$WGS 🐒🍌🧠⏰♾️
1 · Reply
StockbobSquaregainz
StockbobSquaregainz Oct. 24 at 7:00 PM
$WGS get ready for ER
0 · Reply
StockbobSquaregainz
StockbobSquaregainz Oct. 24 at 6:24 PM
$WGS 💥 https://www.investors.com/research/breakout-stocks-technical-analysis/gendedx-stock-genomics-leader-gets-fda-breakthough-device-designation/
0 · Reply
Doozio
Doozio Oct. 24 at 2:42 PM
$WGS eps next week to gap n go during 🐒🍌🧠⏰♾️?
1 · Reply
KacperZeb
KacperZeb Oct. 23 at 9:42 PM
$NTLA $WGS I bought WGS at 30 dollars after an already spectacular run and then sold my shares at 36 dollars while WGS is currently at 120. Now Im holding NTLA shares at 21 dollars and Im not making the same mistake you can bet on that. Once it hits 60 I will sell around half and see what the market sentiment is then. I believe bloomberg will only catch on around that mark.
0 · Reply
Real_deal77
Real_deal77 Oct. 23 at 9:24 PM
I opened (3) new trades against the following tickers: $BYND & $WGS. Total premium rec'd - $11,887.91. 💰https://medium.com/@growthgains/my-investment-journal-how-i-make-3-000-per-week-7800a2138e9a
0 · Reply
CarverX
CarverX Oct. 23 at 9:11 PM
$WGS https://ir.genedx.com/news-releases/news-release-details/genedx-showcases-leadership-genomic-newborn-screening-icons-2025 🚀🚀🚀
0 · Reply
CarverX
CarverX Oct. 23 at 5:43 PM
$WGS Buckle up. This thing is coiled and ready to blast off 🚀🚀🚀
0 · Reply
Latest News on WGS
Halper Sadeh LLC Encourages GeneDx Holdings Corp. Shareholders to Contact the Firm to Discuss Their Rights

Oct 24, 2025, 9:40 AM EDT - 1 day ago

Halper Sadeh LLC Encourages GeneDx Holdings Corp. Shareholders to Contact the Firm to Discuss Their Rights

GeneDx Showcases Leadership in Genomic Newborn Screening at ICoNS 2025

Oct 22, 2025, 8:00 AM EDT - 3 days ago

GeneDx Showcases Leadership in Genomic Newborn Screening at ICoNS 2025

GeneDx Granted FDA Breakthrough Device Designation for its ExomeDx™ and GenomeDx™ Testing

Oct 20, 2025, 8:00 AM EDT - 5 days ago

GeneDx Granted FDA Breakthrough Device Designation for its ExomeDx™ and GenomeDx™ Testing

GeneDX CEO Katherine Stueland on how the company is using AI to save lives

Oct 15, 2025, 3:30 PM EDT - 10 days ago

GeneDX CEO Katherine Stueland on how the company is using AI to save lives

GeneDX CEO Katherine Stueland on if the cuts at NIH impact the company

Oct 15, 2025, 11:45 AM EDT - 10 days ago

GeneDX CEO Katherine Stueland on if the cuts at NIH impact the company

Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot

Oct 15, 2025, 9:15 AM EDT - 10 days ago

Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot

ILMN

GeneDx's Blueprint For The Next Healthcare Revolution

Oct 15, 2025, 2:55 AM EDT - 10 days ago

GeneDx's Blueprint For The Next Healthcare Revolution

How GeneDX CEO Katherine Stueland is using AI to save lives

Oct 14, 2025, 3:17 PM EDT - 11 days ago

How GeneDX CEO Katherine Stueland is using AI to save lives

GeneDx Appoints Dr. Mimi Lee as Chief Precision Medicine Officer

Oct 14, 2025, 8:00 AM EDT - 11 days ago

GeneDx Appoints Dr. Mimi Lee as Chief Precision Medicine Officer

GeneDx to Partner with Florida's Sunshine Genetics Network, Launching Nation's First State-Backed Genomic Newborn Screening Program

Oct 13, 2025, 8:00 AM EDT - 12 days ago

GeneDx to Partner with Florida's Sunshine Genetics Network, Launching Nation's First State-Backed Genomic Newborn Screening Program

GeneDx to Launch Autism Partnership Program to Expand Access to Exome and Genome Testing, including Dedicated SHANK3 Program

Oct 9, 2025, 8:00 AM EDT - 16 days ago

GeneDx to Launch Autism Partnership Program to Expand Access to Exome and Genome Testing, including Dedicated SHANK3 Program

GeneDx to Showcase Pioneering Research Findings at American Society of Human Genetics (ASHG) Annual Meeting

Oct 8, 2025, 8:00 AM EDT - 17 days ago

GeneDx to Showcase Pioneering Research Findings at American Society of Human Genetics (ASHG) Annual Meeting

GeneDx to Report Third Quarter 2025 Financial Results on Tuesday, October 28, 2025

Oct 7, 2025, 8:00 AM EDT - 18 days ago

GeneDx to Report Third Quarter 2025 Financial Results on Tuesday, October 28, 2025

GeneDx Announces First U.S. National Genomic Newborn Screening Initiative Launched with $14.4 Million NIH Award

Oct 1, 2025, 4:01 PM EDT - 24 days ago

GeneDx Announces First U.S. National Genomic Newborn Screening Initiative Launched with $14.4 Million NIH Award

GeneDx Appoints Lisa Gurry as Chief Business Officer to Unlock Data and Information Growth

Sep 30, 2025, 8:00 AM EDT - 25 days ago

GeneDx Appoints Lisa Gurry as Chief Business Officer to Unlock Data and Information Growth

GeneDx Infinity™ Pioneers a New Era of Genetic Medicine with its Introduction at the American Academy of Pediatrics National Conference

Sep 25, 2025, 8:00 AM EDT - 4 weeks ago

GeneDx Infinity™ Pioneers a New Era of Genetic Medicine with its Introduction at the American Academy of Pediatrics National Conference

GeneDx Appoints Visionary AI and Precision Medicine Leader Dr. Thomas Fuchs to Board of Directors

Sep 18, 2025, 8:00 AM EDT - 5 weeks ago

GeneDx Appoints Visionary AI and Precision Medicine Leader Dr. Thomas Fuchs to Board of Directors

GeneDx Holdings Corp. (WGS) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 8, 2025, 10:45 AM EDT - 6 weeks ago

GeneDx Holdings Corp. (WGS) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Seer Appoints Isaac Ro to its Board of Directors

Sep 2, 2025, 7:00 AM EDT - 7 weeks ago

Seer Appoints Isaac Ro to its Board of Directors

SEER

Scott+Scott Attorneys at Law LLP Alerts Investors to Its Investigation Into GeneDx Holdings Corp. (NASDAQ: WGS)

Aug 6, 2025, 9:30 AM EDT - 2 months ago

Scott+Scott Attorneys at Law LLP Alerts Investors to Its Investigation Into GeneDx Holdings Corp. (NASDAQ: WGS)

GeneDx to Participate in Upcoming Investor Conferences

Aug 6, 2025, 8:30 AM EDT - 2 months ago

GeneDx to Participate in Upcoming Investor Conferences

GeneDx Surges Past Q2 Expectations, Sets Up For Strong Year-End Growth

Jul 31, 2025, 10:22 AM EDT - 3 months ago

GeneDx Surges Past Q2 Expectations, Sets Up For Strong Year-End Growth

WGS Investors Have Opportunity to Join GeneDx Holdings Corp. Investigation With the DJS Law Group

Jul 31, 2025, 3:30 AM EDT - 3 months ago

WGS Investors Have Opportunity to Join GeneDx Holdings Corp. Investigation With the DJS Law Group

GeneDx Holdings Corp. Investors: Company Investigated by the Portnoy Law Firm

Jul 30, 2025, 5:07 PM EDT - 3 months ago

GeneDx Holdings Corp. Investors: Company Investigated by the Portnoy Law Firm

GeneDx CEO on rare disease diagnosis: Earlier testing gives families and clinicians more options

Jul 30, 2025, 8:38 AM EDT - 3 months ago

GeneDx CEO on rare disease diagnosis: Earlier testing gives families and clinicians more options

GeneDx Holdings Corp. (WGS) Q2 2025 Earnings Call Transcript

Jul 29, 2025, 5:06 PM EDT - 3 months ago

GeneDx Holdings Corp. (WGS) Q2 2025 Earnings Call Transcript

GeneDx Reports Second Quarter 2025 Financial Results and Business Highlights

Jul 29, 2025, 6:30 AM EDT - 3 months ago

GeneDx Reports Second Quarter 2025 Financial Results and Business Highlights

WGS Investors Have Opportunity to Join GeneDx Holdings Corp. Fraud Investigation with the Schall Law Firm

Jul 28, 2025, 9:43 AM EDT - 3 months ago

WGS Investors Have Opportunity to Join GeneDx Holdings Corp. Fraud Investigation with the Schall Law Firm

GeneDx: Strong Testing Volume And An Invaluable Genomic Database

Jul 15, 2025, 2:52 AM EDT - 3 months ago

GeneDx: Strong Testing Volume And An Invaluable Genomic Database

GeneDx to Report Second Quarter 2025 Financial Results on Tuesday, July 29, 2025

Jul 10, 2025, 8:30 AM EDT - 3 months ago

GeneDx to Report Second Quarter 2025 Financial Results on Tuesday, July 29, 2025

GeneDx Announces Publication of SeqFirst Study Demonstrating Need for First Tier Rapid Genomic Testing for Non-Critical Care Pediatric Inpatients in The Journal of Pediatrics

Jun 25, 2025, 8:30 AM EDT - 4 months ago

GeneDx Announces Publication of SeqFirst Study Demonstrating Need for First Tier Rapid Genomic Testing for Non-Critical Care Pediatric Inpatients in The Journal of Pediatrics

GeneDx Announces American Academy of Pediatrics Recommends Exome and Genome Sequencing as First-Tier Tests for Children with Global Developmental Delay or Intellectual Disability

Jun 23, 2025, 3:17 PM EDT - 4 months ago

GeneDx Announces American Academy of Pediatrics Recommends Exome and Genome Sequencing as First-Tier Tests for Children with Global Developmental Delay or Intellectual Disability

GeneDx Publishes Pioneering Vision for Applying AI to Genomics to Improve and Expedite Diagnosis of Genetic Disease at Scale

May 22, 2025, 8:00 AM EDT - 5 months ago

GeneDx Publishes Pioneering Vision for Applying AI to Genomics to Improve and Expedite Diagnosis of Genetic Disease at Scale

GeneDx: Strong Fundamentals Intact As Market Misreads Test Volume Dip

May 20, 2025, 5:21 AM EDT - 5 months ago

GeneDx: Strong Fundamentals Intact As Market Misreads Test Volume Dip

GeneDx: Time To Buy The Dip

May 14, 2025, 5:35 AM EDT - 5 months ago

GeneDx: Time To Buy The Dip

GeneDx Announces Completion of Fabric Genomics Acquisition

May 7, 2025, 8:30 AM EDT - 6 months ago

GeneDx Announces Completion of Fabric Genomics Acquisition

GeneDx Holdings Corp. (WGS) Q1 2025 Earnings Call Transcript

Apr 30, 2025, 1:15 PM EDT - 6 months ago

GeneDx Holdings Corp. (WGS) Q1 2025 Earnings Call Transcript

GeneDx Reports First Quarter 2025 Financial Results and Business Highlights

Apr 30, 2025, 6:30 AM EDT - 6 months ago

GeneDx Reports First Quarter 2025 Financial Results and Business Highlights

GeneDx: Strengthening Leadership In Genomic Diagnostics

Apr 28, 2025, 11:13 AM EDT - 6 months ago

GeneDx: Strengthening Leadership In Genomic Diagnostics

GeneDx to Acquire Fabric Genomics, Enabling Decentralized, AI-Powered Testing at Global Scale

Apr 16, 2025, 6:00 AM EDT - 6 months ago

GeneDx to Acquire Fabric Genomics, Enabling Decentralized, AI-Powered Testing at Global Scale

GeneDx to Report First Quarter 2025 Financial Results on Wednesday, April 30, 2025

Apr 8, 2025, 8:05 AM EDT - 7 months ago

GeneDx to Report First Quarter 2025 Financial Results on Wednesday, April 30, 2025

GeneDx Expands Commercial Footprint for Exome and Genome Testing with Inborn Errors of Immunity as a New Indication

Apr 3, 2025, 8:00 AM EDT - 7 months ago

GeneDx Expands Commercial Footprint for Exome and Genome Testing with Inborn Errors of Immunity as a New Indication

GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mar 20, 2025, 4:05 PM EDT - 7 months ago

GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Fast Company Recognizes GeneDx as One of the World's Most Innovative Companies

Mar 18, 2025, 7:05 AM EDT - 7 months ago

Fast Company Recognizes GeneDx as One of the World's Most Innovative Companies

GeneDx to Showcase Key Research and Innovation at the 2025 American College of Medical Genetics (ACMG) Annual Meeting

Mar 13, 2025, 8:30 AM EDT - 8 months ago

GeneDx to Showcase Key Research and Innovation at the 2025 American College of Medical Genetics (ACMG) Annual Meeting

Doozio
Doozio Oct. 24 at 11:31 PM
$WGS if $XBI is huckleberry riding then meet $DAVE all the way up da Roger. It’s 🐒🍌🧠⏰♾️
0 · Reply
StockbobSquaregainz
StockbobSquaregainz Oct. 24 at 11:09 PM
$WGS imagine if this ticker was trending one day…
0 · Reply
Doozio
Doozio Oct. 24 at 11:03 PM
$WGS 🐒🍌🧠⏰♾️
1 · Reply
StockbobSquaregainz
StockbobSquaregainz Oct. 24 at 7:00 PM
$WGS get ready for ER
0 · Reply
StockbobSquaregainz
StockbobSquaregainz Oct. 24 at 6:24 PM
$WGS 💥 https://www.investors.com/research/breakout-stocks-technical-analysis/gendedx-stock-genomics-leader-gets-fda-breakthough-device-designation/
0 · Reply
Doozio
Doozio Oct. 24 at 2:42 PM
$WGS eps next week to gap n go during 🐒🍌🧠⏰♾️?
1 · Reply
KacperZeb
KacperZeb Oct. 23 at 9:42 PM
$NTLA $WGS I bought WGS at 30 dollars after an already spectacular run and then sold my shares at 36 dollars while WGS is currently at 120. Now Im holding NTLA shares at 21 dollars and Im not making the same mistake you can bet on that. Once it hits 60 I will sell around half and see what the market sentiment is then. I believe bloomberg will only catch on around that mark.
0 · Reply
Real_deal77
Real_deal77 Oct. 23 at 9:24 PM
I opened (3) new trades against the following tickers: $BYND & $WGS. Total premium rec'd - $11,887.91. 💰https://medium.com/@growthgains/my-investment-journal-how-i-make-3-000-per-week-7800a2138e9a
0 · Reply
CarverX
CarverX Oct. 23 at 9:11 PM
$WGS https://ir.genedx.com/news-releases/news-release-details/genedx-showcases-leadership-genomic-newborn-screening-icons-2025 🚀🚀🚀
0 · Reply
CarverX
CarverX Oct. 23 at 5:43 PM
$WGS Buckle up. This thing is coiled and ready to blast off 🚀🚀🚀
0 · Reply
Doozio
Doozio Oct. 23 at 4:49 PM
$WGS meet DAVE! It’s 🐒🍌🧠⏰♾️
0 · Reply
StockbobSquaregainz
StockbobSquaregainz Oct. 22 at 12:24 PM
$WGS getting interesting here with new BUY ratings coming in
0 · Reply
JarvisFlow
JarvisFlow Oct. 22 at 12:10 PM
BTIG updates rating for GeneDx Holdings ( $WGS ) to Buy, target set at 125 → 140.
0 · Reply
tymtested
tymtested Oct. 21 at 10:07 PM
$WGS eventually, everyone needs GeneDX. This stock is headed to $1,000! Im never selling.
0 · Reply
MahiMe
MahiMe Oct. 20 at 12:03 PM
$WGS $WGS GeneDx Granted FDA Breakthrough Device Designation for its ExomeDx™ and GenomeDx™ Testing https://www.stocktitan.net/news/WGS/gene-dx-granted-fda-breakthrough-device-designation-for-its-exome-dx-7lge591om00r.html
0 · Reply
JarvisFlow
JarvisFlow Oct. 20 at 10:48 AM
Canaccord Genuity updates rating for GeneDx Holdings ( $WGS ) to Buy, target set at 155.
0 · Reply
invest2bfree
invest2bfree Oct. 18 at 8:46 PM
$WGS Incredible
0 · Reply
Meffjenkins
Meffjenkins Oct. 17 at 12:13 AM
$WGS strong like bull
0 · Reply
TimisoaraTitans
TimisoaraTitans Oct. 16 at 6:29 PM
$WGS a 🐷 with 💄 is still a 🐷. Caution. Very illiquid stock.
1 · Reply
Varlamovnyse
Varlamovnyse Oct. 15 at 6:15 PM
$WGS
1 · Reply
CarverX
CarverX Oct. 14 at 5:27 PM
$WGS 2nd inning of this stock with lots of room to run. I see $245 in one year from now 🚀🚀🚀
1 · Reply
resurrect_momo21
resurrect_momo21 Oct. 13 at 4:51 PM
$COCP notice what behind the scenes henchmen crook said about $WGS before $3.4 billion in mkt cap later LOL
0 · Reply